Create Medic (5187) Fundamentals 2026 — P/E 14.7x, Revenue Analysis | SniperIQ
Create Medic (5187) is a JP-listed Healthcare company in Medical - Specialties with a market capitalization of ¥9.4B, trading at ¥1147.00 on the JPX. This SniperIQ fundamentals page covers Create Medic's valuation (P/E 14.7x, P/B 0.6x), profitability (net margin 4.8%), revenue (¥13.6B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Create Medic's market cap?
Create Medic (5187) has a market capitalization of approximately ¥9.4B, trading at ¥1147.00 on the JPX. Market cap moves with the live share price.
What is Create Medic's P/E ratio?
Create Medic's trailing twelve-month P/E ratio is 14.7x, with a price-to-book (P/B) of 0.6x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Create Medic?
Create Medic runs a net profit margin of 4.8%, a gross margin of 43.3%, and an operating margin of 6.7%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Create Medic generate?
Create Medic reported revenue of ¥13.6B for fiscal year 2025, with net income of ¥714M and earnings per share (EPS) of 84.25. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Create Medic pay a dividend?
Create Medic offers a trailing dividend yield of about 4.2%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Create Medic financially healthy?
Create Medic carries a debt-to-equity ratio of 0.05x and a current ratio of 8.00x, with a market beta of 0.29. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Create Medic a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Create Medic (5187) the key facts are: market cap ¥9.4B, P/E 14.7x, revenue ¥13.6B, 52-week range 928-1244. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Create Medic's full fundamentals live
Get Create Medic's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.